Tags

Type your tag names separated by a space and hit enter

[Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels].
Lakartidningen. 2003 Aug 28; 100(35):2674-7.L

Abstract

There is a well-known interaction between vitamin B12, folate, and homocysteine. More unknown is the fact that this interaction might be affected by long-term treatment with levo-dopa in patients with Parkinson's disease. An increase in homocysteine levels and tissue deficiency of vitamin B12 and folate may occur. The responsible doctor should be liberal in checking vitamin B12 and folate status and supplement with appropriate vitamins when needed.

Authors+Show Affiliations

Geriatriska kliniken/NEUROTEC-institutionen, sektionen för geriatrik, Karolinska institutet, Huddinge Universitetssjukhus, Stockholm. johan.lokk@hs.se

Pub Type(s)

English Abstract
Journal Article
Review

Language

swe

PubMed ID

14531126

Citation

Lökk, Johan. "[Treatment With Levodopa Can Affect Latent Vitamin B 12 and Folic Acid Deficiency. Patients With Parkinson Disease Runt the Risk of Elevated Homocysteine Levels]." Lakartidningen, vol. 100, no. 35, 2003, pp. 2674-7.
Lökk J. [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels]. Lakartidningen. 2003;100(35):2674-7.
Lökk, J. (2003). [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels]. Lakartidningen, 100(35), 2674-7.
Lökk J. [Treatment With Levodopa Can Affect Latent Vitamin B 12 and Folic Acid Deficiency. Patients With Parkinson Disease Runt the Risk of Elevated Homocysteine Levels]. Lakartidningen. 2003 Aug 28;100(35):2674-7. PubMed PMID: 14531126.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels]. A1 - Lökk,Johan, PY - 2003/10/9/pubmed PY - 2003/10/18/medline PY - 2003/10/9/entrez SP - 2674 EP - 7 JF - Lakartidningen JO - Lakartidningen VL - 100 IS - 35 N2 - There is a well-known interaction between vitamin B12, folate, and homocysteine. More unknown is the fact that this interaction might be affected by long-term treatment with levo-dopa in patients with Parkinson's disease. An increase in homocysteine levels and tissue deficiency of vitamin B12 and folate may occur. The responsible doctor should be liberal in checking vitamin B12 and folate status and supplement with appropriate vitamins when needed. SN - 0023-7205 UR - https://www.unboundmedicine.com/medline/citation/14531126/[Treatment_with_levodopa_can_affect_latent_vitamin_B_12_and_folic_acid_deficiency__Patients_with_Parkinson_disease_runt_the_risk_of_elevated_homocysteine_levels]_ L2 - http://www.diseaseinfosearch.org/result/5603 DB - PRIME DP - Unbound Medicine ER -